MedTrace Logo

Pilot Study of a National Screening Programme for Bowel Cancer in Norway

NCT01538550 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140000

Last updated 2026-04-14

No results posted yet for this study

Summary

The Norwegian government has funded a pilot study of a national colorectal cancer screening programme. This implies initiation of a screening pilot in the catchment area for two hospitals in Norway. The target population is average risk men and women at age 50-74 years. The programme is designed as a comparative effectiveness programme evaluating acceptance and test performance for two screening methods - fecal occult blood testing (FOBT) and flexible sigmoidoscopy (FS). This protocol describes the main methodological issues, necessary resources and the expected effects.

Conditions

Interventions

PROCEDURE

Flexible sigmoidoscopy

Flexible sigmoidoscopy screening is offered once only

PROCEDURE

iFOBT

Biennial screening with iFOBT

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Giske Ursin, MD, PhD · Norwegian Institute of Public Health

  • Kristin Randel, MD, PhD · Norwegian Institute of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2034-12-31
Completion
2034-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538550 on ClinicalTrials.gov